The deal size was increased to $261M from $200M and priced below last closing price of $44.66. JPMorgan, Goldman Sachs, Evercore ISI and Cantor Fitzgerald are acting as joint book running managers for the offering.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VERA:
- Vera Therapeutics offers to sell up to $200M in common stock
- Vera Therapeutics price target raised to $97 from $75 at Evercore ISI
- Vera Therapeutics price target raised to $73 from $60 at TD Cowen
- Optimistic Buy Rating for Vera Therapeutics Amid Strategic Advancements and Financial Projections
- Vera Therapeutics price target raised to $99 from $52 at JPMorgan